Cargando…
Cyclin G2 regulates canonical Wnt signalling via interaction with Dapper1 to attenuate tubulointerstitial fibrosis in diabetic nephropathy
Cyclin G2 (CCNG2) is an atypical cyclin that inhibits cell cycle progression and is often dysregulated in human cancers. Cyclin G2 in the occurrence and development of diabetic nephropathy (DN), one of the most severe diabetic complications, has not been fully identified. In this study, we investiga...
Autores principales: | Zhao, Chenyang, Gao, Jinlan, Li, Sen, Liu, Qi, Hou, Xiaoyu, Xing, Xuesha, Wang, Danning, Sun, Manni, Wang, Shusen, Luo, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077553/ https://www.ncbi.nlm.nih.gov/pubmed/31978940 http://dx.doi.org/10.1111/jcmm.14946 |
Ejemplares similares
-
Cyclin G2 Suppresses Glomerulosclerosis by Regulating Canonical Wnt Signalling
por: Zhao, Chenyang, et al.
Publicado: (2018) -
Corrigendum to “Cyclin G2 Suppresses Glomerulosclerosis by Regulating Canonical Wnt Signalling”
por: Zhao, Chenyang, et al.
Publicado: (2019) -
Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1
por: Gao, Jinlan, et al.
Publicado: (2018) -
Cyclin G2 reverses immunosuppressive tumor microenvironment and potentiates PD-1 blockade in glioma
por: Li, Sen, et al.
Publicado: (2021) -
Cyclin G2 Inhibits the Warburg Effect and Tumour Progression by Suppressing LDHA Phosphorylation in Glioma
por: Li, Sen, et al.
Publicado: (2019)